In addition to being up-regulated in “limonene and pinene degradation,” the S100A8 gene was also down-regulated in “pantothenic acid and COA biosynthesis.” RNA degradation and tyrosine metabolism for the SILT1 gene were both increased in CAD patients. Here, S100A8 is linked to coronary artery disorder.